Neurology® Podcast

1) Depression in epilepsy and 2) Topic of the month: Child neurology topics. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Chenjie Xia interviews Ms. Kirsten Fiest about her paper on depression in epilepsy. Dr. Chafic Karam is reading our e-Pearl of the week about the art of memory revisited. In the next part of the podcast Dr. Jeff Waugh interviews Dr. Mark Gorman about the topic of autoimmune disorders. The participants had nothing to disclose except Dr. Karam.Dr. Karam served on the editorial team for the Neurology® Resident and Fellow Section.

Topics in biostatistics

1) Prolonged anoxic vegetative state and 2) Topic of the month: Headaches. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matt Flaherty interviews Prof. Luigi Trojano and Dr. Anna Estraneo about their paper on prolonged anoxic vegetative state. Dr. Jen Fugate is reading our e-Pearl of the week about myokymia. In the next part of the podcast Dr. Mike Sowell interviews Dr. Beau Bruce about the topic of pseudotumor cerebri. The participants had nothing to disclose except Drs. Flaherty, Fugate, Bruce and Prof. Trojano.Dr. Flahery serves on the scientific advisory board for CSL Behring; is a consultant for CSL Behring; has a patent pending for non-invasive CNS monitor; receives research support from the NIH and the Principal Investigator of a phase II NINDS-funded trial (STOP-IT) with study drug supplied by Novo Nordisk.Prof. Trojano receives royalties from the publication of the books Neuropsicologia dei Lobi Frontali. Sindrome disesecutive e disturbi del comportamento and Lineamenti di Neuropsicologia Clinica.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Bruce is a consultant for Kaiser Permanente of Georgia; receives research support from Teva Pharmaceutical Industries Ltd., Pfizer Inc, and NIH; was a recipient of the Practice Research Fellowship.

1) Unresponsive wakefulness syndrome and 2) Topic of the month: Headaches. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Thos Cochrane interviews Dr. Boris Kotchoubey about his paper on unresponsive wakefulness syndrome. Dr. Jen Fugate is reading our e-Pearl of the week about periodic alternating nystagmus. In the next part of the podcast Dr. Mike Sowell interviews Dr. Andrew Hershey about the topic of pediatric headache. The participants had nothing to disclose except Drs. Cochrane, Kotchovsky, Fugate and Hershey.Dr. Cochrane receives royalties from the publication of the book First Aid for the Boards: Neurology.Dr. Kotchoubey receives research support from Deutsche Forschungsgemeinschaft.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Hershey serves as an Associate Editor for Headache and Cephalagia; serves on the scientific advisory boards for MAP Pharmaceuticals, Inc., GlaxoSmithKline, Allergan, Inc. and Impax Laboratories, Inc..

1) Incident Parkinson disease and 2) Topic of the month: Headaches. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Morgan interviews Dr. Tien Khoo about his paper on incident Parkinson disease. Dr. Jen Fugate is reading our e-Pearl of the week about paroxysmal dysarthria and ataxia. In the next part of the podcast Dr. Mike Sowell interviews Dr. Alan Finkel about the topic of post-traumatic headache. The participants had nothing to disclose except Drs. Morgan, Khoo, Fugate and Finkel.Dr. Morgan has served on the speakers' bureau of GE Healthcare, GlaxoSmithKline, Teva Pharmaceuticals Industries Ltd., and UCB Pharma; has performed CME for Oakstone Publishing, LLC; is a consultant for Veloxis Pharmaceuticals, Chelsea Therapeutics, and Impax Laboratories, Inc.; receives research support from NIH as a sub-investigator and received compensation for review of medical records and expert witness testimony in multiple cases of litigation involving neurological conditions.Dr. Khoo receives speaker honoraria from Teva and Lundbeck; receives funding for travel from GlaxoSmithKline and receives educational support from a grant with UCB Pharma.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Finkel serves on the speakers' bureau of Allergan, Inc. receives research support from American Headache Society, DVBIC and the American Academy of Neurology.

1) Pre-hospital thrombolysis and 2) Topic of the month: Headaches. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Joachim Weber about his paper on pre-hosptial thrombolysis. Dr. Jen Fugate is reading our e-Pearl of the week about Ondine's curse. In the next part of the podcast Dr. Jen Bickel interviews Dr. Todd Rozen about the topic of cluster headaches. The participants had nothing to disclose except Drs. Audebert and Fugate.Dr. Audebert serves as Associate Editor for Frontiers of Teleneurology; is a consultant for Lundbeck Inc.; receives speaker honoraria from Takeda Pharmaceutical Company Limited, Boehringer Ingelheim, Lundbeck Inc., Bayer Vital, UCB, Sanofi-Syntelabo Inc and Pfizer Inc; receives research support from Center for Stroke Research Berlin funded by the German Federal Ministry of Education and Research and funding of the STEMO project by the Technology Foundation Berlin with co-financing by the European Union; serves on the speakers' bureau of German TeleStroke Networks within the Competence Network Stroke and gave expert testimony in a trial launched by Lundbeck Inc. Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section.

Polyneuropathy

1) Active multiple sclerosis and 2) Topic of the month: Headaches. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michelle Johansen interviews Dr. Jack Ratchford about his paper on active multiple sclerosis. Dr. Jen Fugate is reading our e-Pearl of the week about nummular headache. In the next part of the podcast Dr. Jen Bickel interviews Dr. Gretchen Tietjen about the topic of women and migraine. The participants had nothing to disclose except Drs. Ratchford, Fugate and Tietjen.Dr. Ratchford serves as a consultant for Biogen Idec, Bristol-Myers Squibb and Diogenix, Inc.; and receives research support from Biogen Idec, Novartis, and Sun Pharmaceuticals. Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Tietjen serves as an Associate Editor of Headache; serves on the scientific advisory board for MAP Pharmaceuticals Inc. and holds stock options in Johnson & Johnson and Stryker.

1) Multiple cranial nerve impairment and 2) Topic of the month: Encephalopathy caused by systemic disease. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Stephen Donahue interviews Dr. Vincent Roubeau about his paper on multiple cranial nerve impairment. Dr. Chafic Karam is reading our e-Pearl of the week about neurosyphilis presenting as mesial temporal encephalitis. In the next part of the podcast Dr. Ted Burns interviews Drs. Steven Lewis and Allison Weathers about vitamin deficiency, infection and autoimmunity. The participants had nothing to disclose except Drs. Karam, Burns, Lewis and Weathers.Dr. Karam serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Lewis serves as CME Section Co-Editor for Neurology® and as Associate Editor for Continuum: Lifelong Learning in Neurology®; receives royalties for the books: Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist and anticipates receiving royalties for the book: Neurologic Disorders due to Systemic Disease.Dr. Weathers receives honoraria as an AAN speaker.

1) Orexin receptor antagonism and 2) Topic of the month: Encephalopathy caused by systemic disease. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Drs. Tom Roth and Joe Herring about their paper on orexin receptor antagonism for treatment of insomnia.Dr. Chafic Karam is reading our e-Pearl of the week about central fourth nerve palsies. In the next part of the podcast Dr. Ted Burns interviews Drs. Steven Lewis and Allison Weathers about drugs that can cause encephalopathy. All participants have disclosures.Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.Dr. Roth serves on the scientific advisory boards for Merck, Jazz and Transcept; serves as an editorial board member for Sleep and Sleep Medicine; receives research support from Transcept Pharmaceuticals, Impax Pharmaceuticals, Linguflex LLC and APnes, serves on the speakers' bureau of Purdue Pharma L.P. and is a consultant for Abbott Laboratories, Accadia, Acogolix Inc., Acorda, Actelion Pharmaceuticals Ltd, Addrenex Pharmaceuticals, Inc, Alchemers, Alza Corporation, Ancel, Arena, AstraZeneca, Aventis, AVER, Bayer Schering Pharma, BMS, BTG, Cephalon, Inc., Cypress, Dove, Eisai Inc., Elan Corporation, Eli Lilly and Company, Evotec, Forest Laboratories, Inc., GlaxoSmithKline, Hypnion Inc, Impax Pharmaceuticals, Intec, Intra-Cellular Therapies, Jazz, Johnson & Johnson, King Pharmaceuticals, Lundbeck, Inc., McNeil, MediciNova, Merck, Neurim Pharmaceuticals Ltd, Neurocrine, Neurogen, Novartis, Orexo, Organon Pharmaceuticals, Otsuka Pharmaceuticals, Inc., Prestwick, Proctor & Gamble Pharmaceuticals, Pfizer Inc, Purdue Pharma L.P., Resteva, Roche, Sanofi-aventis, Schoering-Plough Corp., Sepracor Inc., Servier Laboratories, Shire plc, Somaxon Pharmaceuticals, Syrex, Takeda Pharmaceutical Company Limited, TransOral, Yanda, VivoMetrics Inc, Wyeth, Yamanuchi Pharmaceutical, and XenoPort.Dr. Herring is Executive Director, Clinical Neuroscience at Merck; receives research support as an employee at Merck and holds stock options with Merck.Dr. Karam serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Lewis serves as CME Section Co-Editor for Neurology® and as Associate Editor for Continuum: Lifelong Learning in Neurology®; receives royalties for the books: Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist and anticipates receiving royalties for the book: Neurologic Disorders due to Systemic Disease.Dr. Weathers receives honoraria as an AAN speaker.